C4 Therapeutics

+$0.59 (+9.10%) Today
+$0.02 (+0.28%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.

About CCCC

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system.

CEO
Andrew J. Hirsch
Employees
121
Headquarters
Watertown, Massachusetts
Founded
2015

CCCC Key Statistics

Market cap
345.00M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.21M
High today
$7.13
Low today
$6.32
Open price
$6.56
Volume
2.43M
52 Week high
$51.21
52 Week low
$4.84

CCCC Earnings

-$17.55
-$11.70
-$5.85
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure